Indivior Pharmaceuticals Inc (INDV) Stock Analysis

What Indivior Pharmaceuticals Inc does

Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.

Key metrics

ETFs linked to INDV

Broad-market and Healthcare sector ETFs an investor holding Indivior Pharmaceuticals Inc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how INDV fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Indivior Pharmaceuticals Inc?

Indivior Pharmaceuticals Inc trades under the ticker INDV on NASDAQ.

Which exchange is INDV listed on?

INDV is listed on NASDAQ.

What sector does Indivior Pharmaceuticals Inc operate in?

Indivior Pharmaceuticals Inc is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze INDV in a portfolio?

PortView shows INDV's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.